TY - JOUR
T1 - Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a datainclusive machine learning algorithm
AU - Wang, Lujia
AU - Wang, Hairong
AU - D'Angelo, Fulvio
AU - Curtin, Lee
AU - Sereduk, Christopher P.
AU - De Leon, Gustavo
AU - Singleton, Kyle W.
AU - Urcuyo, Javier
AU - Hawkins-Daarud, Andrea
AU - Jackson, Pamela R.
AU - Krishna, Chandan
AU - Zimmerman, Richard S.
AU - Patra, Devi P.
AU - Bendok, Bernard R.
AU - Smith, Kris A.
AU - Nakaji, Peter
AU - Donev, Kliment
AU - Baxter, Leslie C.
AU - Mrugała, Maciej M.
AU - Ceccarelli, Michele
AU - Iavarone, Antonio
AU - Swanson, Kristin
AU - Tran, Nhan
AU - Hu, Leland S
AU - Li, Jing
N1 - Publisher Copyright:
© 2024 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2024/4
Y1 - 2024/4
N2 - Background and objective Glioblastoma (GBM) is one of the most aggressive and lethal human cancers. Intra-tumoral genetic heterogeneity poses a significant challenge for treatment. Biopsy is invasive, which motivates the development of non-invasive, MRI-based machine learning (ML) models to quantify intra-tumoral genetic heterogeneity for each patient. This capability holds great promise for enabling better therapeutic selection to improve patient outcome. Methods We proposed a novel Weakly Supervised Ordinal Support Vector Machine (WSO-SVM) to predict regional genetic alteration status within each GBM tumor using MRI. WSO-SVM was applied to a unique dataset of 318 image-localized biopsies with spatially matched multiparametric MRI from 74 GBM patients. The model was trained to predict the regional genetic alteration of three GBM driver genes (EGFR, PDGFRA and PTEN) based on features extracted from the corresponding region of five MRI contrast images. For comparison, a variety of existing ML algorithms were also applied. Classification accuracy of each gene were compared between the different algorithms. The SHapley Additive explanations (SHAP) method was further applied to compute contribution scores of different contrast images. Finally, the trained WSO-SVM was used to generate prediction maps within the tumoral area of each patient to help visualize the intra-tumoral genetic heterogeneity. Results WSO-SVM achieved 0.80 accuracy, 0.79 sensitivity, and 0.81 specificity for classifying EGFR; 0.71 accuracy, 0.70 sensitivity, and 0.72 specificity for classifying PDGFRA; 0.80 accuracy, 0.78 sensitivity, and 0.83 specificity for classifying PTEN; these results significantly outperformed the existing ML algorithms. Using SHAP, we found that the relative contributions of the five contrast images differ between genes, which are consistent with findings in the literature. The prediction maps revealed extensive intra-tumoral region-toregion heterogeneity within each individual tumor in terms of the alteration status of the three genes. Conclusions This study demonstrated the feasibility of using MRI and WSO-SVM to enable non-invasive prediction of intra-tumoral regional genetic alteration for each GBM patient, which can inform future adaptive therapies for individualized oncology.
AB - Background and objective Glioblastoma (GBM) is one of the most aggressive and lethal human cancers. Intra-tumoral genetic heterogeneity poses a significant challenge for treatment. Biopsy is invasive, which motivates the development of non-invasive, MRI-based machine learning (ML) models to quantify intra-tumoral genetic heterogeneity for each patient. This capability holds great promise for enabling better therapeutic selection to improve patient outcome. Methods We proposed a novel Weakly Supervised Ordinal Support Vector Machine (WSO-SVM) to predict regional genetic alteration status within each GBM tumor using MRI. WSO-SVM was applied to a unique dataset of 318 image-localized biopsies with spatially matched multiparametric MRI from 74 GBM patients. The model was trained to predict the regional genetic alteration of three GBM driver genes (EGFR, PDGFRA and PTEN) based on features extracted from the corresponding region of five MRI contrast images. For comparison, a variety of existing ML algorithms were also applied. Classification accuracy of each gene were compared between the different algorithms. The SHapley Additive explanations (SHAP) method was further applied to compute contribution scores of different contrast images. Finally, the trained WSO-SVM was used to generate prediction maps within the tumoral area of each patient to help visualize the intra-tumoral genetic heterogeneity. Results WSO-SVM achieved 0.80 accuracy, 0.79 sensitivity, and 0.81 specificity for classifying EGFR; 0.71 accuracy, 0.70 sensitivity, and 0.72 specificity for classifying PDGFRA; 0.80 accuracy, 0.78 sensitivity, and 0.83 specificity for classifying PTEN; these results significantly outperformed the existing ML algorithms. Using SHAP, we found that the relative contributions of the five contrast images differ between genes, which are consistent with findings in the literature. The prediction maps revealed extensive intra-tumoral region-toregion heterogeneity within each individual tumor in terms of the alteration status of the three genes. Conclusions This study demonstrated the feasibility of using MRI and WSO-SVM to enable non-invasive prediction of intra-tumoral regional genetic alteration for each GBM patient, which can inform future adaptive therapies for individualized oncology.
UR - http://www.scopus.com/inward/record.url?scp=85189307639&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85189307639&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0299267
DO - 10.1371/journal.pone.0299267
M3 - Article
C2 - 38568950
AN - SCOPUS:85189307639
SN - 1932-6203
VL - 19
JO - PloS one
JF - PloS one
IS - 4 April
M1 - e0299267
ER -